Gu Mi
5 appearances in the program
Sessions & presentations
Integrating biomarker discovery and dose-optimization to drive drug development success
Chair
Topic-Contributed Paper Session · Tue, Aug 4 , 4:00 PM
Current methodology advances and practice in oncology dose optimization studies
Co-Author
Presentation: Dose optimization strategies and practice based on the industry survey and dose optimization whitepaper from a KOL panel discussion
Topic-Contributed Paper Session · Wed, Aug 5 , 8:30 AM
Current methodology advances and practice in oncology dose optimization studies
Speaker
Presentation: The Reversed Multi-Arm Two-Stage (RevMATS) Design in Oncology Dose Optimization
Topic-Contributed Paper Session · Wed, Aug 5 , 8:30 AM
Current methodology advances and practice in oncology dose optimization studies
Co-Author
Presentation: The Reversed Multi-Arm Two-Stage (RevMATS) Design in Oncology Dose Optimization
Topic-Contributed Paper Session · Wed, Aug 5 , 8:30 AM
Revolutionizing Clinical Development with Cutting-Edge Hybrid Designs Incorporating External Data
Speaker
Presentation: Fit-for-Purpose Innovative Designs Utilizing Historic Data
Topic-Contributed Paper Session · Thu, Aug 6 , 8:30 AM